XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	44,500	44,600	13:49

Realtime

Geld

Brief

Zeit

44,500

44,600

13:49

XFRA CAPITAL ADJUSTMENT INFORMATION - 29.05.2024

Das Instrument K6Q SE0003553130 WNTRESEARCH AB SK -,09 EQUITY wird ex Kapitalmassnahme gehandelt am 29.05.2024
The instrument K6Q SE0003553130 WNTRESEARCH AB SK -,09 EQUITY is traded ex capital adjustment on 29.05.2024

Das Instrument SMI BMG2133H2006 TIAN AN MEDICARE HD-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument SMI BMG2133H2006 TIAN AN MEDICARE HD-,01 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 6JU US09060U5074 BIOCARDIA INC.NEW DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024

The instrument 6JU US09060U5074 BIOCARDIA INC.NEW DL-,001 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 6L8 US74587B1017 PULSE BIOSCIENCES DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument 6L8 US74587B1017 PULSE BIOSCIENCES DL-,001 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 26Q NO0010715394 ABL GROUP ASA NA NK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument 26Q NO0010715394 ABL GROUP ASA NA NK-,10 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 1RK US45720L1070 INHIBRX INC. DL -,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument 1RK US45720L1070 INHIBRX INC. DL -,0001 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 4GP MX01UR000007 URBI DESARROLLOS URBANOS EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument 4GP MX01UR000007 URBI DESARROLLOS URBANOS EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument C0Q CH0198251305 COCA-COLA HBC NA.SF 6,70 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument C0Q CH0198251305 COCA-COLA HBC NA.SF 6,70 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Zeit	Aktuelle Nachrichten
10.04.	ABL Group Co-Founder Phil Lenox Rejoins in Marine Operations Role
04.04.	ABL Group ASA: Mandatory notification of trade
02.04.	ABL Group ASA: Acquisition of Techconsult completed
26.02.	Correction: ABL Group ASA - Key information relating to the proposed cash dividend
21.02.	ABL Group ASA: Invitation to presentation of Q4 2024 results

Zeit

Aktuelle Nachrichten

10.04.

ABL Group Co-Founder Phil Lenox Rejoins in Marine Operations Role

04.04.

ABL Group ASA: Mandatory notification of trade

02.04.

ABL Group ASA: Acquisition of Techconsult completed

26.02.

Correction: ABL Group ASA - Key information relating to the proposed cash dividend

21.02.

ABL Group ASA: Invitation to presentation of Q4 2024 results

Zeit	Aktuelle Nachrichten
Mi	BioCardia, Inc. - 8-K, Current Report
15.04.	BioCardia's CardiALLO-HF trial receives DSMB nod to proceed
15.04.	BioCardia, Inc.: BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial	Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of participants treated in low dosage group. The company plans... ► Artikel lesen
15.04.	BioCardia, Inc. - 8-K, Current Report
11.04.	BioCardia, Inc.: BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study

Zeit

Aktuelle Nachrichten

BioCardia, Inc. - 8-K, Current Report

15.04.

BioCardia's CardiALLO-HF trial receives DSMB nod to proceed

15.04.

BioCardia, Inc.: BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial

Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of participants treated in low dosage group. The company plans...
► Artikel lesen

15.04.

BioCardia, Inc. - 8-K, Current Report

11.04.

BioCardia, Inc.: BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study

Zeit	Aktuelle Nachrichten
Do	Mirela Toljan Jakomin Named General Manager Of Coca-Cola HBC Austria
Mi	COCA-COLA HBC A.G.: Announcement of the annual general meeting to be held on 23 May 2025, changes to the Board and confirmation of dividend dates (Correct Repetition)
Mi	Coca-Cola HBC schedules AGM and confirms dividend
Mi	COCA-COLA HBC A.G.: Announcement of the annual general meeting to be held on 23 May 2025, changes to the Board and confirmation of dividend dates
Mi	Coca-Cola HBC sets AGM for May 23, plans board changes

Zeit

Aktuelle Nachrichten

Mirela Toljan Jakomin Named General Manager Of Coca-Cola HBC Austria

COCA-COLA HBC A.G.: Announcement of the annual general meeting to be held on 23 May 2025, changes to the Board and confirmation of dividend dates (Correct Repetition)

Coca-Cola HBC schedules AGM and confirms dividend

COCA-COLA HBC A.G.: Announcement of the annual general meeting to be held on 23 May 2025, changes to the Board and confirmation of dividend dates

Coca-Cola HBC sets AGM for May 23, plans board changes

Zeit	Aktuelle Nachrichten
09.04.	Spotlight Stock Market: Market Notice 64/25- Last day of trading in Opsy Holding AB's subscription option OPSYH TO 8
03.04.	Spotlight Stock Market: Market Notice 61/25 - WntResearch AB changes name to Opsy Holding AB
04.02.	WntResearch CEO comments on reverse acquisition
12.11.24	Spotlight Stock Market: Market Notice 232/24- Last day of trading in WntResearch AB's subscription option WNT TO 7

Zeit

Aktuelle Nachrichten

09.04.

Spotlight Stock Market: Market Notice 64/25- Last day of trading in Opsy Holding AB's subscription option OPSYH TO 8

03.04.

Spotlight Stock Market: Market Notice 61/25 - WntResearch AB changes name to Opsy Holding AB

04.02.

WntResearch CEO comments on reverse acquisition

12.11.24

Spotlight Stock Market: Market Notice 232/24- Last day of trading in WntResearch AB's subscription option WNT TO 7

Zeit	Aktuelle Nachrichten
29.03.	Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call Transcript
28.03.	PULSE BIOSCIENCES, INC. - 8-K, Current Report
27.02.	PULSE BIOSCIENCES, INC. - S-8, Securities to be offered to employees in employee benefit plans
04.02.	Pulse Biosciences has a new CFO
04.02.	Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market

Zeit

Aktuelle Nachrichten

29.03.

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call Transcript

28.03.

PULSE BIOSCIENCES, INC. - 8-K, Current Report

27.02.

PULSE BIOSCIENCES, INC. - S-8, Securities to be offered to employees in employee benefit plans

04.02.

Pulse Biosciences has a new CFO

04.02.

Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market

Zeit	Aktuelle Nachrichten
10.04.	TIANAN MEDICARE (00383): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM
10.04.	TIANAN MEDICARE (00383): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM
10.04.	TIANAN MEDICARE (00383): NOTICE OF ANNUAL GENERAL MEETING
10.04.	TIANAN MEDICARE (00383): PROXY FORM FOR ANNUAL GENERAL MEETING
10.04.	TIANAN MEDICARE (00383): PROPOSALS FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SECURITIES AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL ...

Zeit

Aktuelle Nachrichten

10.04.

TIANAN MEDICARE (00383): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM

10.04.

TIANAN MEDICARE (00383): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM

10.04.

TIANAN MEDICARE (00383): NOTICE OF ANNUAL GENERAL MEETING

10.04.

TIANAN MEDICARE (00383): PROXY FORM FOR ANNUAL GENERAL MEETING

10.04.

TIANAN MEDICARE (00383): PROPOSALS FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SECURITIES AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL ...

Zeit	Aktuelle Nachrichten
28.11.24	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.11.2024	The following instruments on Boerse Frankfurt do have their last trading day on 28.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.11.2024ISIN NameCA38210L1094 GOOD... ► Artikel lesen
28.11.24	XFRA 4GP: AUSSETZUNG/SUSPENSION	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILURBI DESARROLLOS... ► Artikel lesen
29.05.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 29.05.2024	Das Instrument K6Q SE0003553130 WNTRESEARCH AB SK -,09 EQUITY wird ex Kapitalmassnahme gehandelt am 29.05.2024 The instrument K6Q SE0003553130 WNTRESEARCH AB SK -,09 EQUITY is traded ex capital adjustment... ► Artikel lesen

Zeit

Aktuelle Nachrichten

28.11.24

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.11.2024

The following instruments on Boerse Frankfurt do have their last trading day on 28.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.11.2024ISIN NameCA38210L1094 GOOD...
► Artikel lesen

28.11.24

XFRA 4GP: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILURBI DESARROLLOS...
► Artikel lesen

29.05.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 29.05.2024

Unternehmen / Aktien	Kurs	%
ABL GROUP ASA	0,788	-1,00 %
BIOCARDIA INC	1,830	0,00 %
COCA-COLA HBC AG	44,580	-0,22 %
OPSY HOLDING AB	0,047	+6,33 %
PULSE BIOSCIENCES INC	16,100	-4,73 %
TIAN AN MEDICARE LTD	0,076	-3,80 %
URBI DESARROLLOS URBANOS SAB DE CV	4,920	0,00 %

Unternehmen / Aktien

Kurs

ABL GROUP ASA

0,788

-1,00 %

BIOCARDIA INC

1,830

0,00 %

COCA-COLA HBC AG

44,580

-0,22 %

OPSY HOLDING AB